Enliven Therapeutics, Inc (ELVN) Misses Q2 EPS by 49c
Tweet
Share
E-mailGet Alerts ELVN Hot Sheet
Join SI Premium – FREE
Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q2 EPS of ($0.49).
For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Shell Acquires interest in Gulf of America prospect
- JetStream Announces Clearance, an AI Zero Trust Reasoning Engine
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
